CARE-Well App
BehavioralParticipants randomized into this group will be instructed to use the CARE-Well App at least 4 times per week.
NCT Number: NCT04330482
The overall goal of this development project is to combine elements of two efficacious interventions into a mobile health (mHealth) App for informal dementia caregivers. The investigators will conduct a 3-month feasibility trial of the newly-developed CARE-Well App in 40 dementia caregivers to establish acceptability and feasibility of the intervention, study procedures, and outcome measures.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
University of Rhode Island, Kingston, Rhode Island, United States
Caring for a person with dementia is a highly stressful activity and is associated with negative physical and mental health consequences, including increased risk of depression and worse reported health-related quality of life. The proposed project aims to develop and translate an evidence-based, multi-component intervention into a mHealth App that has the potential to increase dementia caregivers' access to support and care.
The investigators will conduct a feasibility trial, in which 40 dementia caregivers will be randomized to receive a computer tablet preloaded with the CARE-well App or preloaded with internet links relevant to dementia and caregiving. Paper outcome measures will be assessed at baseline and end of intervention (3 months) during each study visit. To measure sustainability of the App, the first 10 caregivers from each group will be offered the tablets for an additional month to monitor usage of the App outside the formal trial. The goal of this aim is to determine feasibility of the intervention, study procedures, and outcome measures.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants randomized into this group will be instructed to use the CARE-Well App at least 4 times per week.
Participants randomized into this group will be instructed to use a computer tablet pre-loaded with a list of internet links relevant to dementia caregiving at least 4 times per week.
Time frame: 3 months
Percentage of participants who decline participation because of randomization.
Time frame: 3 months
Percentage of participants enrolled and who remain enrolled for the duration of the study.
Time frame: 3 months
Percentage of participants who used the internet links or the app for the 3-month intervention period.
Time frame: 3 months
Percentage of participants who completed assessments at baseline and follow-up within two weeks of enrollment or completion of the study.
Time frame: 3 months
Percentage of participants who completed the intervention.
Time frame: 3 months
Percentage of participants in a subset of caregivers (10 from each group) interested in continuing to use tablet/App use after formal trial as an estimate of sustainability.
Time frame: 3 months
Percentage of participants satisfied or very satisfied with App technology.
Time frame: 3 months
Percentage of participants satisfied or very satisfied with App content.
Time frame: Baseline and immediately Post-Intervention at 3 months
Depression scale; 0-30 points; higher scores indicate worse outcome.
Time frame: Baseline and immediately Post-Intervention at 3 months
Caregiver burden scale; 0-88 points; higher scores indicate worse outcome.
Time frame: Baseline and immediately Post-Intervention at 3 months
Caregiver reaction to problem behaviors; range 0-96 Higher scores indicate worse outcomes.
Time frame: Baseline and immediately Post-Intervention at 3 months
Caregiver desire to institutionalize care recipient; 0-7 points; high scores indicate worse outcome (or stronger desire to institutionalize).
Rhode Island Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04627662
Alzheimer Disease, Behavior
Portland, Oregon, United States
View Trial DetailsNCT05012410
Alzheimer Disease, Arterial Occlusive Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05150990
Alzheimer Disease, Behavior
Calabasas, California, United States
View Trial DetailsNCT04271046
Alzheimer Disease, Behavior
Seattle, Washington, United States
View Trial Details